首页> 外文期刊>Breast Cancer Research >25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on clinical research
【24h】

25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on clinical research

机译:第25届年度圣安东尼奥乳腺癌研讨会,美国德克萨斯州圣安东尼奥,2002年12月10日至14日,有关临床研究的最新信息

获取原文
       

摘要

The Annual San Antonio Breast Cancer Symposium has become a key forum for the presentation and discussion of both translational scientific aspects as well as clinical aspects of breast cancer care. In this report of the 25th Annual Meeting, an update of the salient clinical data is presented. The findings of the CALGB 9741 trial, an updated analysis of the Arimidex, Tamoxifen, Alone or in Combination study, and other significant paper and poster presentations are discussed. Summaries are also given of the clinical plenary lectures and minisymposia on adjuvant therapy and aromatase inhibitors.Keywords: adjuvant chemotherapy, anastrozole, aromatase inhibitor, tamoxifen, trastuzumab
机译:每年一度的圣安东尼奥乳腺癌研讨会已经成为介绍和讨论乳腺癌治疗的转化科学方面以及临床方面的重要论坛。在第25届年会的这份报告中,介绍了重要临床数据的更新。讨论了CALGB 9741试验的结果,对Arimidex,他莫昔芬,单独或联合研究的更新分析,以及其他重要的论文和海报展示。总结了有关辅助治疗和芳香化酶抑制剂的临床全体讲座和小型研讨会。关键词:辅助化疗,阿那曲唑,芳香化酶抑制剂,他莫昔芬,曲妥珠单抗

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号